Renatus Tactical Acquisition Corp I - Warrant (RTACW)

On our desk, we are monitoring the slight contraction in institutional sponsorship for RTACW. With fund count dropping from 30 to 27 in Q2 2026 and exits outpacing new first-time investments, the market sentiment feels somewhat defensive despite the warrants holding steady around $0.70.

Reviewing the Q2 2026 10-Q filing details, Renatus Tactical Acquisition Corp I maintains total assets of $252.7 million—virtually all parked safely in a trust account holding cash and U.S. government securities backing Class A shares redeemable at $10.45. However, the presence of going concern disclosures requires strict risk management protocols.

From a quantitative screening standpoint, the CirclFi Deep Alpha Valuation Engine suggests caution, indicating that 0 out of 5 models project upside for the underlying RTAC stock at current pricing. This bearish consensus on the equity side naturally introduces valuation ceiling questions for the RTACW warrants.

Our risk committee is tracking the market cap of RTACW at approximately $7.96 million. With historical IPO details showing a May 2025 launch of 24,150,000 units and a concurrent private placement of 3,821,591 warrants, liquidity and dilution dynamics remain core factors in our scenario modeling.

When analyzing special purpose acquisition companies like Renatus Tactical, my primary clinical focus centers on burn rate versus interest income. For the six months ended June 30, 2026, the company posted net income of $3.53 million driven heavily by $4.20 million in interest income off trust assets, which temporarily offsets minimal operating overhead.